This review discusses the evolving role of percutaneous coronary intervention as an alternative to coronary artery bypass grafting for the treatment of unprotected left main coronary artery disease.
LMCA PCI may be considered in select patients; leaves open need for randomized outcome data versus CABG.
Coronary artery bypass grafting (CABG) is known as the gold standard treatment of unprotected left main coronary artery (LMCA) disease and has the highest level of evidence in European and American recommendations. However development of endovascular methods of treatment, and first of all decrease of in-stent-restenosis allow us to consider angioplasty and stenting of LMCA as an alternative method to CABG. The comparative world analysis of results of percutaneous coronary interventions and CABG is provided in article. It tells also how efficiency of percutaneous coronary interventions depends on such factors as lesion localization, diabetes, type of drug-eluting stent.
No takes yet. Share an insight, caveat, or question.
Vlasov et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: